Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Durect Corporation

Fisher, D., DURECT Corporation, Cupertino, CA, USA Personal Communication, 2002. [Pg.262]

J.W. Gibson, S.S. Miller, J.C. Middleton, and A.J. Tipton, High viscosity liquid controlled delivery system and medical or surgical device, US Patent 7833543, assigned to Durect Corporation (Cupertino, CA), November 16,2010. [Pg.263]

Development of the Chronogesic subcutaneous sufentanil system was halted during phase 111 clinical trials at the discretion of DURECT Corporation secondary to a design flaw that caused a small fraction of units to prematurely shut down delivery of the drug prior to the end of the intended delivery period. Clinical trials are on hold and will resume when redesign of the delivery system is complete [2]. Due to this development, trial information is not readily available. [Pg.470]

See other pages where Durect Corporation is mentioned: [Pg.1332]    [Pg.3360]    [Pg.1332]    [Pg.3360]   
See also in sourсe #XX -- [ Pg.111 ]



SEARCH



© 2024 chempedia.info